LPM3480392

DRUG2 trials

Sponsors

Luye Pharma Group Ltd.

Conditions

Healthy

Phase 1

An Exploratory Study of LPM3480392 at Different Infusion Rates in Chinese Healthy Subjects

CompletedNCT05857449

Luye Pharma Group Ltd.Healthy

Start: 2021-11-08End: 2022-03-09Updated: 2023-05-12

A Dose-escalation Study of LPM3480392 in Chinese Healthy Subjects

CompletedNCT05862974

Luye Pharma Group Ltd.Healthy

Start: 2021-02-25End: 2021-11-02Updated: 2023-05-17